UPDATE 1-Biogen takes control of JVs in Italy, Switzerland

BOSTON, Sept. 6 (Reuters) - Biogen Idec Inc said on Tuesday it has taken control of two joint ventures it has with Italian biotechnology company Dompe Group to sell Biogen's multiple sclerosis drugs Avonex and Tysabri.

. Read More

Free Web Hosting